124 related articles for article (PubMed ID: 10961022)
1. Stability of capsules containing omeprazole in enteric coated pellets.
Palummo M; Cingolani A; Dall L; Volonté MG
Boll Chim Farm; 2000; 139(3):124-8. PubMed ID: 10961022
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of dissolution properties and degradation products of omeprazole in enteric-coated pellets.
Storpirtis S; Rodrigues D
Drug Dev Ind Pharm; 1998 Nov; 24(11):1101-7. PubMed ID: 9876567
[TBL] [Abstract][Full Text] [Related]
3. Stability of ranitidine tablets subjected to stress and environmental conditions, by HPLC.
Volonté MG; Yuln G; Mandrile A; Longo R; Cingolani A
Boll Chim Farm; 2001; 140(5):316-21. PubMed ID: 11680085
[TBL] [Abstract][Full Text] [Related]
4. In vitro study on capsule formulations of omeprazole containing enteric coated granules.
Pandey VP; Phanindrudu A; Manavalan R; Livingston J
Boll Chim Farm; 2002; 141(6):419-22. PubMed ID: 12577509
[TBL] [Abstract][Full Text] [Related]
5. Quantification of omeprazole degradation by enteric coating polymers: an UV-VIS spectroscopy study.
Riedel A; Leopold CS
Pharmazie; 2005 Feb; 60(2):126-30. PubMed ID: 15739901
[TBL] [Abstract][Full Text] [Related]
6. Tableting and stability evaluation of enteric-coated omeprazole pellets.
Türkoğlu M; Varol H; Celikok M
Eur J Pharm Biopharm; 2004 Mar; 57(2):279-86. PubMed ID: 15018985
[TBL] [Abstract][Full Text] [Related]
7. Spectrophotometric and chromatographic determination of omeprazole in pharmaceutical formulations.
Gallardo V; López-Viota M; Sierra J; Ruiz MA
Pharm Dev Technol; 2009; 14(5):516-23. PubMed ID: 19267285
[TBL] [Abstract][Full Text] [Related]
8. Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole.
He W; Fan LF; Du Q; Xiang B; Li CL; Bai M; Chang YZ; Cao DY
Chem Pharm Bull (Tokyo); 2009 Feb; 57(2):122-8. PubMed ID: 19182399
[TBL] [Abstract][Full Text] [Related]
9. Dissolution of omeprazole from delayed-release solid oral dosage forms.
Farinha A; Bica A; Martins JM; Pais JP
Drug Dev Ind Pharm; 2000 Jul; 26(7):785-90. PubMed ID: 10872100
[TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability of two enteric-coated capsules of omeprazole in healthy volunteers.
Garg SK; Chugh Y; Tripathi SK; Kumar N; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):96-9. PubMed ID: 8458683
[TBL] [Abstract][Full Text] [Related]
11. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
Kibria G; Islam KM; Jalil RU
Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
[TBL] [Abstract][Full Text] [Related]
12. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
13. [Differences in the release of omeprazole in 4 commercial preparations: influence of pH and ionic concentration].
Navarro MA; Raei N; Torres F; Granero L; García-Zaragoza E; Esplugues JV; Esteban Peris J
Gastroenterol Hepatol; 1998 Feb; 21(2):63-70. PubMed ID: 9549180
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients.
Thomson AB; Kirdeikis P; Lastiwka R; Röhss K; Sinclair P; Olofsson B
Can J Gastroenterol; 1997; 11(8):657-60. PubMed ID: 9459044
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
Breier AR; Paim CS; Steppe M; Schapoval EE
J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
[TBL] [Abstract][Full Text] [Related]
16. Generic omeprazole delayed-release capsules: in vitro performance evaluations.
Moore T; Smith A; Ye W; Toler DY; Westenberger BJ; Lionberger R; Raw A; Yu L; Buhse LF
Drug Dev Ind Pharm; 2009 Aug; 35(8):917-21. PubMed ID: 19555236
[TBL] [Abstract][Full Text] [Related]
17. In vitro dissolution of oral modified-release tablets and capsules in ethanolic media.
Smith AP; Moore TW; Westenberger BJ; Doub WH
Int J Pharm; 2010 Oct; 398(1-2):93-6. PubMed ID: 20667505
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole--a new formulation.
Armstrong D
Can J Gastroenterol; 1997; 11(8):655-6. PubMed ID: 9459043
[No Abstract] [Full Text] [Related]
19. Assessment of the pharmaceutical quality of omeprazole capsule brands marketed in Egypt.
El-Sayed A; Boraie NA; Ismail FA; El-Khordagui LK; Khalil SA
East Mediterr Health J; 2007; 13(6):1427-37. PubMed ID: 18341192
[TBL] [Abstract][Full Text] [Related]
20. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
Bendas ER; Ayres JW
Eur J Pharm Biopharm; 2008 Aug; 69(3):977-85. PubMed ID: 18424095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
